XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $596K invested in XTL Biopharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$50K |
Top Sellers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $272K | 198,888 | – | – |
|
|
NC
2
Noked Capital
Tel Aviv,
Israel
| $272K | 198,888 | – | – |
|
|
3
Morgan Stanley
New York
| $50K | 36,831 | +699 | +2% |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | 1,224 | -2,104 | -63% |
|
|
5
Invesco
Atlanta,
Georgia
| – | – | -25,961 | Closed |
|
|
6
Citadel Advisors
Miami,
Florida
| – | – | -18,254 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|